There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 100 μg |
| Product Overview | Recombinant SARS coronavirus Tor2 Spike glycoprotein (NP_828851.1) RBD (Arg306-Phe527) was produced in CHO cells6-His tag at the C-terminus. Measured by its binding ability in a functional ELISA with recombinant human ACE-2. |
| Biological Activity | Measured by its binding ability in a functional ELISA with recombinant human ACE-2. |
| Source | CHO cells |
| Species | SARS coronavirus Tor2 |
| Fragment | RBD (Arg306-Phe527) |
| Tag | 6-His tag at the C-terminus |
| Predicted N Terminal | Arg306 |
| Predicted MW | 26 kDa |
| Purity | >95%, determined by SDS-PAGE. |
| Endotoxin Level | <0.1 EU/μg, determined by LAL method. |
| Conjugation | Unconjugated |
| Target | S |
| Full Name | Spike glycoprotein |
| Gene ID | 1489668 |
| Accession Number | NP_828851.1 |
| Background | The spike (S) protein of SARS coronavirus Tor2 is considered as a protective Ag for vaccine design. |
| Alternate Names | E2 |